X-Products’ range provides state-of-the-art automated testing for Dose Content Uniformity and Particle Size Determination including Andersen and NGI impactors.
A case study reviewing inhalation devices. Capsule-based devices in particular, offer many benefits to patients in terms of precise dosing, ease of use and dose visibility. For manufacturers, capsule-based DPI technology provides greater freedom to innovate and differentiate their products.
The aim of the white paper is to increase awareness of the various ways that the test environment may be influencing results and to provide practical suggestions for improvement.
The nasal drug product market is currently the focus of considerable research activity. Here, we examine the advantages and challenges of nasal drug delivery, plus the testing options available.
This definitive guide for OINDP analysts combines details about our comprehensive range of testing equipment with easy-to-understand information on the latest regulatory requirements and best practices.
This case study examines how Experic worked with a mid-sized pharmaceutical company to address the challenges hindering the advancement of their product and illustrates the importance of introducing filling studies during formulation development to avoid costly delays and reformulation.
AdheResp, using Formosa Pharma's APNT technology, overcomes standard mesh nebulizer challenges to efficiently deliver nanosuspension formulations with optimal aerosol performance.
In the November 2023 Issue #154 of ONdrug Delivery, HCmed Innovations looks at the advantages of customisable nebulizer platforms for new combination products.
The PreciseInhale® platform integrates aerosol sources with in vitro, ex vivo, and in vivo exposure modules, enabling precision dosing and predictive pharmacokinetic insights for inhalation research.
Our new NGI cooler is a practical, easy to use system that improves the accuracy and reproducibility of inhaler product testing for solution-based devices.
Part 1: A stepwise guide for nasal spray and pMDI development. Part 2: A novel human-realistic approach for in vitro characterization to better predict in vivo performance.
Within the sphere of DPIs, HPMC-capsule-based DPIs are a compelling alternative due to capsule properties of puncturing, powder aerosolization, control of internal capsule surface and performance with low-moisture contents.
This article will describe some new developments in low moisture content capsule technology to assist with the development of capsule-based DPI products for hygroscopic and very moisture-labile APIs.
This article will describe some established and emerging imaging systems that can be utilized to picture two-piece capsules and will highlight potential benefits and limitations of each.
A discussion of the rising prominence of biologics in the pharmaceuticals market and how dry powder inhalers utilizing hard capsules are a promising potential delivery method for these new drugs.
Set against the backdrop of environmental concerns over HFC propellants used in pressurised metered-dose inhalers, this article presents evidence supporting the adoption of dry-powder inhalers as an attractive alternative.
